- Benchmark ASINB0FPQ6461V
- MarketplaceUS
- Category ID3761461
- Analyzed Products
- Keywordhome health
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing Cost¥8.99estimated
- Data Date2026-07-31
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场现在不值得进入：当前只验证到 1 个新品牌 suzamed、1 个新ASIN B0FPQ6461V，表面上新品牌成功率是 100%，但样本太小，不能代表可复制机会；更关键的是，这个唯一成功案例的利润率只有 12.4%，低于你要求的 15% 合格线，说明它能跑通但并不轻松赚钱。市场也没有出现30+新品牌涌入的典型过度拥挤信号，所以不是“品牌海啸式饱和”，但它已经呈现出低利润、靠功能差异化支撑的特征，对小商家不友好。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
#Budget Requirement
Listing结论很明确：这个市场不适合现在进入，500,000 CNY 只能覆盖单个ASIN的前期启动，不能代表长期投入安全。 当前样本里只有 1 个新品牌 suzamed 的 1 个新ASIN B0FPQ6461V，表面上 100% 盈利，但这不是一个可复制的市场信号，更像是单点成功案例，暂时不能据此判断有稳定机会。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?0.00%New listing success rate (new brands):100.00%Which new brands have these successful new listings?Alternatives- 处方药原包装 + 药房提供的纸质/电子用药说明：如果用户主要是为了随身携带胰岛素，直接使用药品原包装再配合药袋/说明单，成本更低、获取更方便，也更适合短时外出。
- 普通保温午餐袋/小型保冷袋 + 一次性冰袋：比专用胰岛素冷藏包更便宜、选择更多，适合对温控要求没那么严格、只需短时间外出的场景。
- 家用软质冷藏收纳包/便携药品袋：可兼容多种药物与耗材，不必购买单一用途产品，适合同时携带血糖仪、试纸、针头等日常用品。
- 可重复使用的凝胶冰袋 + 小收纳包组合：用户可按需要自行拼装，比带温度显示的专用款更省钱，也更容易在超市/药店直接买到。
- 旅行化妆包式分隔收纳盒 + 冷源配件：如果核心诉求是“整理”和“方便取用”，这种方案通常更轻便、款式更多、价格也更低。
- 药房/诊所领取的临时药品保冷方案：例如一次性保冷袋、样品冷包或院内短途转运袋，适合临时外出、就医复诊等低频需求，购买决策门槛更低。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场当前不适合进入：我们只看到 1 个新品牌 suzamed、1 个新上架 ASIN B0FPQ6461V，样本太小，完全谈不上 30~100+ 新品牌那种过度拥挤；但它已经表现出明显的“靠差异化功能吃饭”的特征，且这个成功样本的利润率只有 12.4%，低于你要求的 15% 及格线，说明它不是一个轻松赚钱的市场。对大品牌来说，能做，但要带着创新和较重投放进去；对小商家来说，若没有独特功能与执行能力，不建议贸然进入。
Most investment in new productsNew products with Highest revenueLeast investment in new productssuzamed
Recent Monthly Revenue (USD):$1,499.00(100pcs/month)B0FPQ6461V (4.5/5 (393 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable#Differentiations
Unique productsCommon productsDifferentiation:- Product features and designs are too common without differentiation
B0FPQ6461V (4.5/5 (393 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不值得进入：样本里只有1个可识别产品，当前没有出现你要警惕的30+新品牌涌入，但也根本看不到足够的可复制机会，属于“数据极少、难以下结论但不适合贸然下场”的状态。 目前唯一可验证的成功案例是 suzamed 的 B0FPQ6461V：售价14.99美元，利润率12.4%，月销100件，最近月营收1499美元，早期投入约7465美元，其中广告约1677美元；这说明它能跑通，但利润率只有12.4%，低于你要求的“15%以上才算更稳妥”的门槛，靠的是功能差异化而不是高利润爆发。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0FPQ6461Vsuzamed2025-09-07Yes$14.99100pcs$1499.012.4%$185.88Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0FPQ6461Vsuzamed2025-09-07Yes$14.99100pcs$1499.012.4%$185.88#New Product Success Rates
Listing这个市场不适合进入：当前样本里只有 1 个可分析品牌 suzamed，且它一个新品牌就拿下了全部可见的盈利新品，但这不代表市场机会大，反而说明样本过窄、信息不足，不能据此判断为可复制的低门槛机会。更关键的是，唯一的成功案例 B0FPQ6461V 需要约 7465.02 美元前期投入，最近月利润只有 185.88 美元、利润率 12.4%，属于勉强可盈利，不是高回报模型。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
suzamedNo data available#Success Rate by Entry Time
Listing这个市场目前不值得进入。 近一年只有 1 个新品牌 suzamed 产生了可确认的盈利新上架，表面上看不是“品牌洪水式涌入”，但市场的真实信号更像是样本极少、结论不稳：没有看到持续的新品牌成功潮，也没有看到明确的利润扩张趋势，现有可验证成功只来自一个品牌和一个 ASIN，不能把它当成可复制的机会。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 1 0 0 0 0 2026 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 0 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 1 0 0 0 0 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success Casessuzamed Temp Display Insulin Cooler Travel Case, 2PCS 150g Ice Pack, Green
This listing is deemed profitablePrice (USD)$14.99Released TypeNew Release (2025-09-07)Brand is a new entry in this marketSize and Weight21.7 x 12.2 x 6.0 cm, 449.00gProfitable Factors
Distinct functions and featuresDesign & Appearance
绿色外观更偏清爽、偏户外便携风格, 带实时温度显示窗口的便携式胰岛素冷藏包，整体是拉链手提旅行盒造型Key Buying Motive
内置温度显示，可直观看到包内温度，提升用药温控安全性Target Customers
需要在出差、旅行、露营等场景随身携带胰岛素及糖尿病用品的人群Early Investment
Investment
Monthly Revenue (Recent) (USD)$1,499.00100 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight8.64% / 12.40%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight-5.98% / -2.23%Peak / Non PeakSales & BSR Performance